Compounds > asiaticoside
Page last updated: 2024-09-02

asiaticoside and Triple Negative Breast Neoplasms

asiaticoside has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, Z; Huang, X; Jia, Z; Li, X; Xia, J; Yu, X1

Other Studies

1 other study(ies) available for asiaticoside and Triple Negative Breast Neoplasms

ArticleYear
Asiaticoside hampers epithelial-mesenchymal transition by promoting PPARG expression and suppressing P2RX7-mediated TGF-β/Smad signaling in triple-negative breast cancer.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:5

    Topics: Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; PPAR gamma; Receptors, Purinergic P2X7; Triple Negative Breast Neoplasms

2023